Skip to main content
SpringerLink
Log in

Botulinum Toxins

  • Chapter
  • First Online:
Update in Cosmetic Dermatology

Abstract

Nowadays, botulinum toxin is the most common non surgical procedure for facial rejuvenation. By blocking acethylcoline release at the neuromuscular junctions, it reduces the motility of the muscles of facial expression, leading to a smoother and more youthful appearance. Botulinum toxin is used in a number of cosmetic indications in the face, neck and chest, including eyebrow reshaping, nasal tip droop, repeated nasal flare, drooping mouth corner, and gingival smile. This chapter discusses the used techniques for the different indications as well as possible side effects of these treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aoki RK (2003) Pharmacology and immunology of Botulinum toxin type A. Clin Dermatol 21:476–480

    Article  PubMed  Google Scholar 

  2. Ascher B, Talarico S, Cassuto D et al (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type a (Speywood Unit) – part I: upper facial wrinkles. J Eur Acad Dermatol Venereol 24(11):1278–1284

    Article  PubMed  CAS  Google Scholar 

  3. Ascher B, Talarico S, Cassuto D et al (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part II: wrinkles on the middle and lower face, neck and chest. J Eur Acad Dermatol Venereol 24(11):1285–1295

    Article  PubMed  CAS  Google Scholar 

  4. Atamoros FP (2003) Botulinum toxin in the lower one third of the face. Clin Dermatol 21:505–512

    Article  PubMed  Google Scholar 

  5. Beer K, Waibel J (2007) Botulinum toxin type A enhances the outcome of fractional resur­facing of the cheek. J Drugs Dermatol 6(11):1151–1152

    PubMed  Google Scholar 

  6. Borodic G (2007) Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Facial Plast Surg Clin North Am 15(1):11–16

    Article  PubMed  Google Scholar 

  7. Carruthers A, Carruthers J (2001) Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 20:71–84

    Article  PubMed  CAS  Google Scholar 

  8. Carruthers A, Carruthers J, Lowe NJ et al (2004) One year, randomized, multicenter, two period study of the safety and efficacy of repeated treatments with botulinum toxin type-A in patients with Glabelar lines. J Clin Res 7:1

    Google Scholar 

  9. Carruthers J, Carruthers A (2003) Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg 29(5):468–476

    Article  PubMed  Google Scholar 

  10. Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114(Suppl 6):1–22

    Google Scholar 

  11. Carruthers JD, Glogau RG, Blitzer A, Facial Aesthetics Consensus Group Faculty (2008) Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies – consensus recommendations. Plast Reconstr Surg 121(Suppl 5):5–30

    Google Scholar 

  12. Coleman KR, Carruthers J (2006) Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 19(3):177–188

    Article  PubMed  Google Scholar 

  13. de Sa Earp AP, Marmur ES (2008) The five D´s of botulinum toxin: doses, dilution, diffusion, duration and dogma. J Cosmet Laser Ther 10:93–102

    Article  PubMed  Google Scholar 

  14. Doft MA, Kasten JL, Ascherman JA (2011) Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon’s experience with 53 consecutive patients. Aesthetic Plast Surg 35(6):1079–1086

    Article  PubMed  Google Scholar 

  15. Dressler D, Saberi FA, Barbosa ER (2005) Botulinum toxin: mechanism of action. Arq Neruropsiquiatr 63(1):180–185

    Article  Google Scholar 

  16. Flynn TC (2003) Periocular Botulinum toxin. Clin Dermatol 21:498–504

    Article  PubMed  Google Scholar 

  17. Flynn TC, Carruthers J, Carruthers A (2001) Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 27(8):703–708

    Article  PubMed  CAS  Google Scholar 

  18. Glogau RG (2002) Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes. Clin J Pain 18(Suppl 6):191–197

    Article  Google Scholar 

  19. Grein S, Mander GJ, Taylor HV (2008) Xeomin® is stable without refrigeration: complexing proteins are not required for stability of botulinum neurotoxin type a preparations. Toxicon 51:10

    Article  Google Scholar 

  20. Hexsel D, Dal’Forno T (2003) Type A Botulinum toxin in the upper aspect of the face. Clin Dermatol 21:488–497

    Article  PubMed  Google Scholar 

  21. Hexsel D, Dal’Forno T (2009) The upper trunk: décolleté wrinkles and breast lift. In: Ascher B, Landau M, Rossi B (eds) Injection treatments in cosmetic surgery. Informa Healthcare, London, pp 153–157

    Google Scholar 

  22. Hexsel D, Hexsel C (2010) Botulinum toxins. In: Robinson JK, Hanke CW, Siegel DM, Fratila A (eds) Surgery of the skin: procedural dermatology. Mosby Elsevier, Edinburgh, pp 433–446

    Chapter  Google Scholar 

  23. Hexsel DM, Almeida AT, Rutowitsch M et al (2003) Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg 29(5):523–529

    Article  PubMed  Google Scholar 

  24. Cohen JL, Dayan SH, Cox SE et al (2012) OnabotulinumtoxinA Dose-Ranging Study for Hyperdynamic Perioral Lines. Dermatol Surg 38(9):1497–1505

    Article  PubMed  CAS  Google Scholar 

  25. Hexsel D, Castro IA, Zechmeister D et al (2004) Multicenter, double-blind study of the efficacy of injections with botulinum toxin A reconstituted up to six consecutive weeks before application. Dermatol Surg 30(5):823

    Article  PubMed  Google Scholar 

  26. Hexsel D, DalForno T, Soirefmann M, et al. Effective, low cost, simple, disposable cooling tool for patient comfort in common dermatologic procedures. Dermatol Surg (in press)

    Google Scholar 

  27. Hexsel D, Mazzuco R, Dal’Forno T et al (2007) Botulinum toxin for facial wrinkles; history and future. Expert Ver Dermatol 2(4):417–426

    Article  CAS  Google Scholar 

  28. Hexsel D, Rutowitsch M, Castro LC et al (2009) Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to fifteen weeks prior injection. Dermatol Surg 35(6):933–939; discussion 940

    Article  PubMed  CAS  Google Scholar 

  29. Klein AW, Carruthers A, Fagien S, Lowe NJ (2008) Comparisons among botulinum toxins: an evidence-based review. Plast Reconstr Surg 121(6):413–422

    Article  Google Scholar 

  30. Kogos L (2002) Mental Wrinkles. In: Hexsel D, de Almeida AT (eds) Cosmetic use of botulinum toxin. AGE, São Paulo, pp 167–170

    Google Scholar 

  31. Levy PM (2007) The “Nefertiti lift”: a new technique for specific re-contouring of the jawline. J Cosmet Laser Ther 9(4):249–252

    Article  PubMed  Google Scholar 

  32. Mazzuco R, Hexsel D (2010) Gummy smile and botulinum toxin: a new approach based on the gingival exposure area. J Am Acad Dermatol 63(6):1042–1051

    Article  PubMed  CAS  Google Scholar 

  33. Pena MA, Alam M, Yoo SS (2007) Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg 26(1):29–33

    Article  PubMed  CAS  Google Scholar 

  34. Rzany B, Ascher B, Monheit G (2010) Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol 24(1):1–14

    Article  PubMed  CAS  Google Scholar 

  35. Salti G, Ghersetich I (2008) Advanced botulinum toxin techniques against wrinkles in the upper face. Clin Dermatol 26(2):182–191

    Article  PubMed  Google Scholar 

  36. Sposito MM (2004) Toxina botulínica tipo A – propriedades farmacológicas e uso clínico. Acta Fisiatr (Suppl 1):1–44

    Google Scholar 

  37. Vadoud-Seyedi J, Simonart T (2007) Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol 156(5):986–989

    Article  PubMed  CAS  Google Scholar 

  38. Wollina U, Konrad H (2005) Managing adverse events associated with botulinum toxin type-A: a focus o cosmetic procedures. Am J Clin Dermatol 6(3):141–150

    Article  PubMed  Google Scholar 

  39. Yamauchi PS, Lask G, Lowe NJ (2004) Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing. J Cosmet Laser Ther 6(3):145–148

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Pontifícia Universidade Catolica do Rio Grande do Sul (PUC-RS), Brazilian Center for Studies in Dermatology, Porto Alegre, RS, Brazil

    Doris Hexsel M.D.

  2. Brazilian Center for Studies in Dermatology, Porto Alegre, RS, Brazil

    Doris Hexsel M.D.

  3. 782 Dr. Timoteo, St., 90570-040, Porto Alegre, RS, Brazil

    Doris Hexsel M.D.

  4. Department of Dermatology, Brazilian Center for Studies in Dermatology, Porto Alegre, RS, Brazil

    Cristiano Brum M.D.

Authors
  1. Doris Hexsel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristiano Brum M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Doris Hexsel M.D. .

Editor information

Editors and Affiliations

  1. Leonard M. Miller School of Medicine, Department of Dermatology, University of Miami, Belle Meade Island Drive 881, Miami, 33138, Florida, USA

    Antonella Tosti

  2. , Clinica Hexsel de Dermatologia, Pontifícia Universidade Católica do Rio, Dr Timoteo Street 782, Porto Alegre, 90570-040, Rio Grande do Sul, Brazil

    Doris Hexsel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hexsel, D., Brum, C. (2013). Botulinum Toxins. In: Tosti, A., Hexsel, D. (eds) Update in Cosmetic Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34029-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-34029-1_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-34028-4

  • Online ISBN: 978-3-642-34029-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation